Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally. The company develops OpRegen, an allogeneic retinal...
Leadership
Brian M. Culley M.A., M.B.A.
CEO, President & Director
Jill Ann Howe
Chief Financial Officer
George A. Samuel III, J.D.
General Counsel & Company Secretary
Ioana C. Hone
Director of Investor Relations
Charlotte Hubbert Ph.D.
Vice President of Corporate Strategy & Development
Priyantha Herath M.D., Ph.D.
Senior VP & Head of Clinical Operations
Rami Skaliter M.Sc., Ph.D.
Chief Executive Officer of Cell Cure Neurosciences
Alexandra Hernandez
Senior Director of Finance & Controller
Harold D. Waitz Ph.D.
Vice President of Regulatory Affairs & Quality Control
